@levenj01 @hswapnil @ChristosArgyrop Ok, you got me to drop into the rabbit hole 😂😂 Great paper reviewing sglt1/2’s, which includes phase iii trials on their efficacy in type I dm. https://t.co/ftHoBGDyTF
9,808 followers
195 followers
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives | Cardiovascular Diabetology | Full Text. TIL there are SGLT1 inhibitors! 🤯🤯 #TwitteRx #pharmacy https://t.co/o0OlvGm5AX
63 followers
$AKBA consider loading up on $LXRX Suspect that valuation will climb x 4 within the next 6 months or buyout/partnership worth billions Fairly derided at this point https://t.co/dUekNvZA9O
1,491 followers
👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻